EU and South Africa conditionally clear GSK/Pfizer
The European Commission has ordered Pfizer to globally divest its ThermaCare brand to proceed with the company’s proposed €10.8 billion joint venture with GlaxoSmithKline, while South Africa’s enforcer also imposed remedies on the deal.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.